Jiangsu Lianhuan Pharmaceutical Co., Ltd. (SHA:600513)
China
· Delayed Price · Currency is CNY 23.10
-0.38 (-1.62%)
Mar 10, 2026, 3:00 PM CST
SHA:600513 Revenue
Jiangsu Lianhuan Pharmaceutical had revenue of 797.12M CNY in the quarter ending September 30, 2025, with 53.81% growth. This brings the company's revenue in the last twelve months to 2.60B, up 11.26% year-over-year. In the year 2024, Jiangsu Lianhuan Pharmaceutical had annual revenue of 2.16B, down -0.63%.
Revenue (ttm)
2.60B
Revenue Growth
+11.26%
P/S Ratio
2.58
Revenue / Employee
1.87M
Employees
1,388
Market Cap
6.70B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.16B | -13.64M | -0.63% |
| Dec 31, 2023 | 2.17B | 218.94M | 11.20% |
| Dec 31, 2022 | 1.96B | 309.34M | 18.80% |
| Dec 31, 2021 | 1.65B | 259.78M | 18.74% |
| Dec 31, 2020 | 1.39B | 95.71M | 7.42% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ChengDa Pharmaceuticals | 374.46M |
| Beijing SL Pharmaceutical | 578.61M |
| Jinghua Pharmaceutical Group | 1.45B |
| Tibet Duo Rui Pharmaceutical | 177.11M |
| Guizhou Xinbang Pharmaceutical | 5.73B |
| Shanghai Kaibao Pharmaceutical CO.,Ltd | 1.17B |
| HPGC Renmintongtai Pharmaceutical | 10.22B |
| Beijing Beilu Pharmaceutical | 1.13B |